151 related articles for article (PubMed ID: 7523320)
21. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
Yu HS; Kao CH; Yu CL
J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
[TBL] [Abstract][Full Text] [Related]
22. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
Kim NH; Lee AY
Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
[TBL] [Abstract][Full Text] [Related]
23. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
24. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
[TBL] [Abstract][Full Text] [Related]
25. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis.
Elsherif R; Mahmoud WA; Mohamed RR
Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical Analysis of GDNF and Its Cognate Receptor GFRα-1 Protein Expression in Vitiliginous Skin Lesions.
Adly MA; Assaf HA; Abdel-Rady SF; Ahmed NS; Hussein MR
J Cutan Med Surg; 2016; 20(2):130-4. PubMed ID: 26337382
[TBL] [Abstract][Full Text] [Related]
27. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo.
Schallreuter KU; Wood JM; Pittelkow MR; Buttner G; Swanson N; Korner C; Ehrke C
Arch Dermatol Res; 1996; 288(1):14-8. PubMed ID: 8750929
[TBL] [Abstract][Full Text] [Related]
28. Melanin and melanosome complexes in long standing stable vitiligo--an ultrastructural study.
Bartosik J; Wulf HC; Kobayasi T
Eur J Dermatol; 1998 Mar; 8(2):95-7. PubMed ID: 9649719
[TBL] [Abstract][Full Text] [Related]
29. Lesional skin in vitiligo exhibits delayed in vivo reepithelialization compared to the nonlesional skin.
Gupta A; Chauhan A; Priya A; Mantri B; Wadhokar M; Dalave K; Shah B; Gokhale RS; Batra VV; Singh A
Wound Repair Regen; 2020 May; 28(3):307-314. PubMed ID: 32003499
[TBL] [Abstract][Full Text] [Related]
30. Keratinocyte damage in vitiligo.
Bhawan J; Bhutani LK
J Cutan Pathol; 1983 Jun; 10(3):207-12. PubMed ID: 6190850
[TBL] [Abstract][Full Text] [Related]
31. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo.
Abdel-Naser MB; Krüger-Krasagakes S; Krasagakis K; Gollnick H; Abdel-Fattah A; Orfanos CE
Pigment Cell Res; 1994 Feb; 7(1):1-8. PubMed ID: 8072943
[TBL] [Abstract][Full Text] [Related]
32. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation.
Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731
[TBL] [Abstract][Full Text] [Related]
33. Vitiligo - The story from within: A transmission electron microscopic study before and after narrow-band ultraviolet B.
Fawzy MM; El Maadawi ZM; Hegazy RA; El Fatah NS
Ultrastruct Pathol; 2016; 40(5):265-75. PubMed ID: 27594347
[TBL] [Abstract][Full Text] [Related]
34. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
[TBL] [Abstract][Full Text] [Related]
35. Involvement of non-melanocytic skin cells in vitiligo.
Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
[TBL] [Abstract][Full Text] [Related]
36. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
38. Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.
Raam L; Kaleviste E; Šunina M; Vaher H; Saare M; Prans E; Pihlap M; Abram K; Karelson M; Peterson P; Rebane A; Kisand K; Kingo K
Front Immunol; 2018; 9():2707. PubMed ID: 30515176
[TBL] [Abstract][Full Text] [Related]
39. Repigmentation of vitiliginous skin by cultured cells.
Brysk MM; Newton RC; Rajaraman S; Plott T; Barlow E; Bell T; Penn P; Smith EB
Pigment Cell Res; 1989; 2(3):202-7. PubMed ID: 2475866
[TBL] [Abstract][Full Text] [Related]
40. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes.
Kim NH; Jeon S; Lee HJ; Lee AY
J Invest Dermatol; 2007 Nov; 127(11):2612-7. PubMed ID: 17522703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
